[
    [
        {
            "time": "",
            "original_text": "A股一季报首亏比例上升，海外市场业绩“受伤”亏损",
            "features": {
                "keywords": [
                    "A股",
                    "一季报",
                    "首亏",
                    "海外市场",
                    "业绩",
                    "亏损"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "海外"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股一季报首亏比例上升，海外市场业绩“受伤”亏损",
                "Correlation": 3,
                "Sentiment": 2,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【面包财报】沃森生物：2019年营业总收入11.21亿元，净利润1.42亿元",
            "features": {
                "keywords": [
                    "沃森生物",
                    "2019年",
                    "营业总收入",
                    "净利润"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【面包财报】沃森生物：2019年营业总收入11.21亿元，净利润1.42亿元",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：2019年营业总收入11.21亿元，净利润1.42亿元",
            "features": {
                "keywords": [
                    "沃森生物",
                    "2019年",
                    "营业总收入",
                    "净利润"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物：2019年营业总收入11.21亿元，净利润1.42亿元",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：全年扣非净利仅增6%，13价肺炎疫苗或成业绩爆发点",
            "features": {
                "keywords": [
                    "沃森生物",
                    "全年",
                    "扣非净利",
                    "增长",
                    "13价肺炎疫苗",
                    "业绩爆发点"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物：全年扣非净利仅增6%，13价肺炎疫苗或成业绩爆发点",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "专注于自主产品 云南沃森生物2019年营收增长近三成",
            "features": {
                "keywords": [
                    "沃森生物",
                    "2019年",
                    "营收增长",
                    "自主产品"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "专注于自主产品 云南沃森生物2019年营收增长近三成",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "沃森生物2020一季度亏损超1800万元，2019年不分红 亏损",
            "features": {
                "keywords": [
                    "沃森生物",
                    "2020一季度",
                    "亏损",
                    "2019年",
                    "不分红"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物2020一季度亏损超1800万元，2019年不分红 亏损",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]